Wuhan Kangzhu Biotechnology Co., Ltd.
Wuhan Pearl Biotechnology produces and sells in vitro diagnostic reagents, passed GMP certification, offering products in multiple lines for various medical tests.
Introduction
Wuhan Pearl Biotechnology Co., Ltd. specializes in the development, production, and sales of in vitro diagnostic reagents. It is the pioneering institution in China to achieve GMP certification by the National Food and Drug Administration. The company's comprehensive product system includes enzyme-linked immunosorbent assays (ELISAs), glucose measurements, biochemical tests, chemical analyses, and radiation assessment, encompassing a wide range of applications such as infectious disease diagnosis, tumor screening, and women's health testing.
More Websites
The company Anton Paar was registered in 1922 by the founder of the same name in Graz (Austria) and has made a name for itself as the world market leader in the measurement of density, concentration and dissolved carbon dioxide as well as in the fielJedawi is mainly engaged in the development and production of new drug design and advanced pharmaceutical intermediaries, has a huge European and American large pharmaceutical companies customer base, has established a catalog of more than 20,000 com